Page last updated: 2024-08-17

isoprene and Carcinoma, Hepatocellular

isoprene has been researched along with Carcinoma, Hepatocellular in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Cardozo, MT; de Conti, A; Moreno, FS; Ong, TP	1
Ellipilli, S; Guo, P; Ho, YS; Lee, WJ; Li, X; Vieweger, M; Wang, H	1

Reviews

1 review(s) available for isoprene and Carcinoma, Hepatocellular

Article	Year
Chemoprevention of hepatocarcinogenesis with dietary isoprenic derivatives: cellular and molecular aspects. Current cancer drug targets, 2012, Nov-01, Volume: 12, Issue:9 Topics: Animals; Antineoplastic Agents; Butadienes; Carcinoma, Hepatocellular; Diet; Hemiterpenes; Humans; Liver Neoplasms; Molecular Targeted Therapy; Pentanes	2012

Other Studies

1 other study(ies) available for isoprene and Carcinoma, Hepatocellular

Article	Year
Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance. Journal of controlled release : official journal of the Controlled Release Society, 2021, 02-10, Volume: 330 Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Delivery Systems; Drug Resistance, Neoplasm; Liver Neoplasms; Mice; MicroRNAs; Nanoparticles; Paclitaxel; Pharmaceutical Preparations; Rubber	2021

Article

Year

Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance.

Journal of controlled release : official journal of the Controlled Release Society, 2021, 02-10, Volume: 330

Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Delivery Systems; Drug Resistance, Neoplasm; Liver Neoplasms; Mice; MicroRNAs; Nanoparticles; Paclitaxel; Pharmaceutical Preparations; Rubber

2021